Search results for "MHC restriction"

showing 10 items of 41 documents

The Transporter Associated With Antigen Processing (TAP): Structural Integrity, Expression, Function, and Its Clinical Relevance

2001

BACKGROUND: The transporter associated with antigen processing (TAP), a member of the family of ABC transporters, plays a crucial role in the processing and presentation of the major histocompatibility complex (MHC) class I restricted antigens. TAP transports peptides from the cytosol into the endoplasmic reticulum, thereby selecting peptides matching in length and sequence to respective MHC class I molecules. Upon loading on MHC class I molecules, the trimeric MHC class I/beta2-microglobulin/ peptide complex is then transported to the cell surface and presented to CD8+ cytotoxic T cells. Abnormalities in MHC class I surface expression have been found in a number of different malignancies, …

Protein ConformationAntigen processingAntigen presentationCD1Transporter associated with antigen processingBiologyMHC restrictionMajor histocompatibility complexModels BiologicalCell biologyGene Expression RegulationAntigenMHC class IGeneticsbiology.proteinHumansMolecular MedicineATP-Binding Cassette TransportersMolecular BiologyGenetics (clinical)Research ArticleMolecular Medicine
researchProduct

Large scale preparation of human MHC class II+ integrin beta(1)+ Tregs.

2010

Abstract The human CD4 + CD25 + FoxP3 + regulatory T cell population (Tregs) contains both MHC class II + and MHC class II − cells. MHC class II + Tregs belong to the integrin α 4 β 1 + subpopulation and exclusively execute contact-dependent suppressive activity. Here we present a method optimized for isolation of these MHC class II expressing Tregs from large leukaphereses products using magnetic microbeads that achieves a reproducible purity of more than 90% and enables the use of this small-sized Treg population in pre-clinical application and basic research.

Regulatory T cellImmunologyPopulationIntegrinchemical and pharmacologic phenomenaIntegrin alpha4beta1T-Lymphocytes RegulatoryT-Lymphocyte SubsetsmedicineImmune ToleranceImmunology and AllergyHumansIL-2 receptorLeukapheresiseducationCells CulturedMHC class IIeducation.field_of_studybiologyImmunomagnetic SeparationHistocompatibility Antigens Class IIInterleukin-2 Receptor alpha SubunitFOXP3hemic and immune systemsForkhead Transcription FactorsT lymphocyteMHC restrictionFlow CytometryCell biologyHigh-Throughput Screening Assaysmedicine.anatomical_structureImmunologyCD4 Antigensbiology.proteinJournal of immunological methods
researchProduct

Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.

2013

Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system

Settore MED/04 - Patologia GeneraleButyrophilin 3A1ImmunologyAntigen presentationbiochemical phenomena metabolism and nutritionMHC restrictionBiologyANTIGENS CDInfectious DiseasesImmune systemphosphoantigenAntigenButyrophilinImmunologyImmunology and AllergyCytotoxic T cellhuman gamma delta T cells.CD8
researchProduct

An MHC class II-expressing T cell clone presenting conventional antigen lacks the ability to present bacterial superantigen.

1995

We have analyzed the response of rat T cells to myelin basic protein (MBP) and the bacterial superantigen, staphylococcal enterotoxin E (SEE). Rat T cells reactive with MBP can respond to SEE presented by spleen cells but not to SEE presented by LOA, a rat T cell clone that expresses both I-A and I-E MHC class II molecules, even though LOA is much more efficient than splenic APC in the presentation of MBP. The inability of LOA to present superantigen is not due to a structural difference in MHC II molecules between LOA and the splenic APC or to differential expression of major accessory/adhesion molecules, including CD2, CD5, CD4 and CD44, on LOA. The non-responsiveness of SEE/LOA-induced T…

Staphylococcus aureusT cellT-LymphocytesImmunologyAntigen-Presenting CellsEnterotoxinsInterferon-gammaAntigenparasitic diseasesMHC class ImedicineImmunology and AllergyCytotoxic T cellAnimalsClonal AnergyMHC class IIAntigens BacterialSuperantigensbiologyAntigen processingChemistryHistocompatibility Antigens Class IIMyelin Basic ProteinGeneral MedicineMHC restrictionClone CellsRatsmedicine.anatomical_structureRats Inbred LewImmunologybiology.proteinCD8International immunology
researchProduct

The Role of the Major Histocompatibility Gene Complex in Murine Cytotoxic T Cell Responses

1980

Publisher Summary An interpretation of the function of major histocompatibility complex (MHC) in cytotoxic T cell responses requires making certain assumptions, which, because of the lack of experimental data, are often based on intuition. This chapter discusses some specific aspects of the role of MHC in cytotoxic T cell responses. It also summarizes the expression of T cell-mediated responses to alloantigens. It also focuses on H-2-restricted cytotoxic T lymphocytes (CTL) responses and discusses the influence of the MHC on cytotoxic T cell specificity and CTL responsiveness against foreign antigens. T cell responses to alloantigens mirror all the functional activities seen in H-2-restrict…

T cellchemical and pharmacologic phenomenaBiologyMHC restrictionMajor histocompatibility complexmedicine.anatomical_structureAntigenImmunologyMHC class Imedicinebiology.proteinCytotoxic T cellAntigen-presenting cellCD8
researchProduct

Heat shock protein-peptide complexes for use in vaccines

1996

Abstract The heat shock proteins gp96, HSP70, and HSP90 are complexed to a diverse array of cellular proteins and peptides as a consequence of their chaperone functions. There is good experimental evidence that vaccination with these heat shock protein-peptide complexes elicit immune responses against chaperoned peptide antigens. As shown with gp96, this requires internalization of the heat shock protein-peptide complexes by macrophages and processing of the chaperoned peptides for class I restricted presentation. Via this process, primarily CD8+ antigen-specific T cells are primed by gp96 vaccination. This might represent a general mechanism for priming of MHC-class I restricted T cells by…

VaccinesbiologyAntigen processingImmunologyAntigen presentationCell BiologyMHC restrictionMajor histocompatibility complexMolecular biologyHsp70Cell biologyAntigenAntigens NeoplasmNeoplasmsHeat shock proteinMHC class Ibiology.proteinAnimalsHumansImmunology and AllergyPeptidesHeat-Shock ProteinsMolecular ChaperonesJournal of Leukocyte Biology
researchProduct

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

1998

Malignant transformation is often associated with genetic alterations providing tumor cells with mechanisms for escape from immune surveillance. Human and murine tumors of various origin as well as in vitro models of viral and oncogenic transformation express reduced levels of major histocompatibility complex (MHC) class I antigens resulting in decreased sensitivity to MHC class I-restricted cytotoxic T lymphocyte (CTL)-mediated lysis. We here investigate whether the suppressed MHC class I surface expression of ras-transformed fibroblasts is due to dysregulation of the genes of the antigen-processing machinery, the peptide transporters TAP-1 and TAP-2 and the proteasome subunits LMP-2 and L…

biologyCD74Antigen processingMHC class I antigenImmunologyMHC class Ibiology.proteinCD1Immunology and AllergyTransporter associated with antigen processingMHC restrictionMolecular biologyCD8European Journal of Immunology
researchProduct

Major Histocompatibility Complex Modulation and Loss

2002

biologyCD74ModulationMHC class IImmunologyAntigen presentationbiology.proteinMinor histocompatibility antigenHuman leukocyte antigenMHC restrictionMajor histocompatibility complexCell biologyCancer Immune Therapy
researchProduct

Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin

2000

In murine tumor cell lines, downregulation of MHC class I surface expression has been frequently detected, but the underlying molecular mechanisms of such deficiencies have not been defined. In this study, murine tumor cell lines of different histology derived from spontaneous or from chemical-induced tumors were analyzed for the expression of multiple components of the major histocompatibility complex (MHC) class I antigen-processing machinery (APM), including the peptide transporter TAP, the interferon (IFN)-gamma inducible proteasome subunits and several chaperones. The tumor cell lines analyzed demonstrated a heterogeneous expression pattern of various APM components. In comparison to c…

biologyMHC class I antigenAntigen processingImmunologyGeneral MedicineTransporter associated with antigen processingMHC restrictionMajor histocompatibility complexBiochemistryMolecular biologyTapasinMHC class IGeneticsbiology.proteinImmunology and AllergyCalreticulinTissue Antigens
researchProduct

Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide …

2001

MHC class I tetramers containing peptide epitopes are sensitive tools for detecting antigen-specific CD8(+) T-cell responses. We demonstrate here that binding of HLA-A2 tetramers to CD8(+) T cells specific for the melanoma-associated antigen Melan-A/MART-1 can be fine-tuned by altering either the bound peptide epitope or residues in the alpha 3 domain of HLA-A2, which is important for CD8 binding. Antigen-specific T cells expressing high levels of CD8 could be detected using HLA-A2 tetramers containing the peptide AAGIGILTV, an epitope which is naturally processed and presented from Melan-A/MART-1. In contrast, low CD8-expressing, antigen-specific T cells could be detected efficiently only …

chemistry.chemical_classificationCancer ResearchbiologyT-cell receptorPeptideMHC restrictionVirologyMolecular biologyEpitopeOncologychemistryAntigenMHC class IMART-1 Antigenbiology.proteinCD8International Journal of Cancer
researchProduct